The Board of Directors of Divi’s Laboratories is scheduled to meet on February 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the third quarter and nine months ending December 31, 2025. The trading window, which was closed on January 1, 2026, will remain closed until 48 hours after the results are declared, with an anticipated reopening on February 13, 2026.
Board Meeting Scheduled
Divi’s Laboratories has announced a meeting of its Board of Directors to be held on February 11, 2026. The primary agenda is to review and approve the unaudited financial performance of the company.
Financial Results on the Agenda
The board will specifically address the standalone and consolidated financial results for both Q3 (Oct-Dec) and the nine-month period ending December 31, 2025. This includes a detailed review of revenue, profitability, and key financial metrics.
Trading Window Closure
As previously communicated on December 31, 2025, the trading window for company securities has been closed since January 1, 2026. This closure will remain in effect until 48 hours following the public announcement of the aforementioned financial results. The anticipated reopening of the trading window is February 13, 2026.
Source: BSE
